Evidence map›Paper›PMID 36713733›Full record

ArticleACS omega2023

Attention-Based Graph Neural Network for Molecular Solubility Prediction.

Waqar Ahmad, Hilal Tayara, Kil To Chong

Abstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Can Graph Neural Networks Understand Chemical Elements?Journal of chemical information and modeling · 2026
    Article
  2. Article
  3. Predicting SJournal of chemical theory and computation · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Machine Learned Classification of Ligand Intrinsic Activities at HumanbioRxiv : the preprint server for biology · 2024
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Waqar AhmadDepartment of Electronics and Information Engineering, Jeonbuk National University, Jeonju54896, South Korea.
Hilal TayaraSchool of International Engineering and Science, Jeonbuk National University, Jeonju54896, South Korea.ORCID https://orcid.org/0000-0001-5678-3479
Kil To ChongDepartment of Electronics and Information Engineering, Jeonbuk National University, Jeonju54896, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug discovery (DD) research is aimed at the discovery of new medications. Solubility is an important physicochemical property in drug development. Active pharmaceutical ingredients (APIs) are essential substances for high drug efficacy. During DD research, aqueous solubility (AS) is a key physicochemical attribute required for API characterization. High-precision in silico solubility prediction reduces the experimental cost and time of drug development. Several artificial tools have been employed for solubility prediction using machine learning and deep learning techniques. This study aims to create different deep learning models that can predict the solubility of a wide range of molecules using the largest currently available solubility data set. Simplified molecular-input line-entry system (SMILES) strings were used as molecular representation, models developed using simple graph convolution, graph isomorphism network, graph attention network, and AttentiveFP network. Based on the performance of the models, the AttentiveFP-based network model was finally selected. The model was trained and tested on 9943 compounds. The model outperformed on 62 anticancer compounds with metric Pearson correlation

Identifiers

PMID36713733
PMCPMC9878542

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.